Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography, and the nuclear imaging modalities of PET and SPECT.

How the shape, size and location of calcified carotid plaques affect stroke risk
A new analysis provides further insight into factors affecting plaque stability and subsequent ischemic events
FDA approves expanded use of PET imaging agent
The product's updated indications include quantification and long-term monitoring of amyloid plaques on imaging.
Low dose GBCA effective, safe for pediatric imaging
Although gadopiclenol is approved for adults and children ages 2 and older, there is limited data on its use in the pediatric population.
'Powerful' new PET agent improves the diagnosis of triple-negative breast cancer
The agent “exhibits powerful tumor delineation” in challenging cases of determining cancer subtypes, and could potentially lead to more personalized, effective treatment strategies.
Emergency physicians make more mistakes when interpreting imaging of multiple organs
A new analysis details the prevalence of interpretation errors in EDs, the factors that influence them and how they affect patient care.

Actinium-225 is a therapeutic radioisotope used to deliver targeted radiation that kills cancer cells.

Premenopausal women benefit most from spiral breast computed tomography, experts said this week.

The Centers for Medicare & Medicaid Services wants to lower the starting age from 55 down to 50 while also modifying required smoking pack-years.

There is “immense variability” in how this is handled in clinical practice, with a lack of evidence-based literature, experts wrote in JACR.

Providers are struggling to address disparities in minority communities, the American Lung Association reported.

It’s part of a suite of solutions from the Chicago-based technology giant, embedded in mobile imaging devices to improve quality.

Doctors armed with these new tools can spot early signs of chronic liver diseases, which is crucial to possibly reversing progression.

USPSTF wants to unearth ways to increase uptake in clinical practice, particularly among those at higher risk of death from the disease.